SCHEMBL6382012

SCHEMBL6382012

CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)C(C)C)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC15A2 Q16348 1/20 0.46
CTSD P07339 2/20 0.46
GHSR Q92847 2/20 0.45
F2 P00734 2/20 0.43
C5AR1 P21730 2/20 0.43
HRH1 P35367 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CALCRL Q16602 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9747695 1.00 SLC15A2 (0.46) SLC15A2CTSDGHSRF2C5AR1
SCHEMBL9389399 1.00 SLC15A2 (0.46) SLC15A2CTSDGHSRF2C5AR1
SCHEMBL10625459 0.99 SLC15A2 (0.45) SLC15A2CTSDGHSRF2C5AR1
SCHEMBL5527046 0.93 GHSR (0.44) SLC15A2CTSDGHSRF2C5AR1
SCHEMBL9751592 0.91 OPRK1 (0.45) CTSDGHSRC5AR1
SCHEMBL9751589 0.91 OPRK1 (0.45) CTSDGHSRC5AR1
SCHEMBL30353033 0.91 SLC15A2 (0.55) SLC15A2GHSRF2C5AR1
SCHEMBL9641165 0.91 SLC15A2 (0.42) SLC15A2GHSRF2C5AR1HRH1
SCHEMBL9390320 0.90 SLC15A2 (0.54) SLC15A2GHSRCALCRL
SCHEMBL7806530 0.90 SLC15A2 (0.54) SLC15A2GHSRCALCRL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1565149-A1 STIMULATION OF HAIR GROWTH BY COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND MINOXIDIL PROCYTE CORPORATION (US) 2005-08-24 EP disclosed
EP-1534215-A1 COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND SOFT TISSUE FILLERS PROCYTE CORPORATION (US) 2005-06-01 EP disclosed
US-20040142853-A1 Stimulation of hair growth by compositions containing peptide copper complexes and minoxidil PROCYTE CORPORATION 2004-07-22 US disclosed
WO-2004043415-A1 STIMULATION OF HAIR GROWTH BY COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND MINOXIDIL PROCYTE CORPORATION (US) 2004-05-27 WO disclosed
WO-2004004671-A1 COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND SOFT TISSUE FILLERS PROCYTE CORPORATION (US) 2004-01-15 WO disclosed
US-20030064494-A1 Novel isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD and use of the said SOD in cosmetic, food, and pharmaceutical compositions COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 2003-04-03 US disclosed
US-6485950-B1 Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2002-11-26 US disclosed
EP-0522004-B1 USE OF COPPER(II) CONTAINING COMPOUNDS TO ACCELERATE WOUND HEALING PROCYTE CORP (US) 1999-12-15 EP disclosed
US-5550183-A Metal-peptide compositions and methods for stimulating hair growth PROCYTE CORPORATION (US) 1996-08-27 US disclosed
US-5470876-A Antialopecia, superoxide dismutase activity PROCTOR PETER H (US) 1995-11-28 US disclosed
US-5118665-A Enhance or restore resistance of mammals to damage caused by release of reactive oxygen species PROCYTE CORPORATION (US) 1992-06-02 US disclosed
US-5059588-A METHODS AND COMPOSITIONS FOR HEALING BONE USING GLY HIS LYS: COPPER PROCYTE CORPORATION, INCORPORATED (US) 1991-10-22 US disclosed
WO-1991012267-A1 ANTI-OXIDATIVE AND ANTI-INFLAMMATORY METAL:PEPTIDE COMPLEXES AND USES THEREOF PROCYTE CORPORATION (US) 1991-08-22 WO disclosed
US-5023237-A Using oligopeptide containing glycine, histidine, and lysine PROCYTE CORPORATION (US) 1991-06-11 US disclosed
EP-0420914-A1 COSMETIC AND SKIN TREATMENT COMPOSITIONS. PROCYTE CORP (US) 1991-04-10 EP disclosed
WO-1991003488-A1 METHODS AND COMPOSITIONS FOR HEALING ULCERS PROCYTE CORPORATION (US) 1991-03-21 WO disclosed
WO-1989012441-A1 COSMETIC AND SKIN TREATMENT COMPOSITIONS PROCYTE CORPORATION (US) 1989-12-28 WO disclosed
WO-1988008695-A1 METHODS FOR STIMULATING HAIR GROWTH PROCYTE CORPORATION (US) 1988-11-17 WO disclosed
WO-1988008851-A1 METHOD FOR INDUCING BIOLOGICAL COVERINGS IN WOUNDS PROCYTE CORPORATION (US) 1988-11-17 WO disclosed
US-4767753-A GLYCYL-HISTIDYL-LYSINE DERIVATIVES PROCYTE CORPORATION (US) 1988-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142853-A1 Stimulation of hair growth by compositions containing peptide copper complexes and minoxidil PDGFA, FGF1, FGF2 SLC15A2 3458/4885CTSD 2986/4885GHSR 96/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.